Thermo Fisher Scientific | TMO - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Abbott USD 52.06B 69M 2026-03
Agilent USD 7.12B 214M 2026-03
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Bio Techne USD 2.09B 74.32M 2026-03
Bio-Rad Laboratories USD 6.85B 602.3M 2026-03
Boston Scientific USD 25.86B 1.63B 2026-03
Bruker USD 2.46B 35.9M 2025-12
Charles River Laboratories USD 2.9B 265.94M 2026-03
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.32B 21M 2026-03
Edwards Lifesciences USD 10.33B 10.1M 2026-03
General Electric Aerospace USD 17.64B 417M 2026-06
Henry Schein USD 3.27B 21M 2026-03
Illumina USD 2.68B 47M 2026-03
Intuitive Surgical USD 18.17B 693.9M 2026-06
IQVIA Holdings USD 6.22B 282M 2026-03
Laboratory Of America USD 8.73B 108.8M 2026-03
Medtronic USD 48.99B 128M 2025-12
Mettler Toledo International USD -41.88M 18.25M 2026-03
Myriad Genetics USD 337.4M 30.6M 2026-03
Olympus JPY 812.04B 38.69B 2026-03
OraSure Technologies USD 313.32M 27.5M 2026-03
Quest Diagnostics USD 7.37B 196M 2026-03
Repligen USD 2.11B 666K 2026-03
Revvity USD 7.25B 125.54M 2025-12
Stryker USD 22.42B 635M 2025-12
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Veracyte USD 1.34B 34.83M 2026-03
Waters USD 2.56B 230.55M 2025-12
Zimmer Biomet Holdings USD 12.68B 16.1M 2026-03